DK3658553T3 - Mellemprodukter som er anvendelige til syntesen af aminopyrimidinderivater, fremgangsmåde til fremstilling deraf og fremgangsmåde til fremstilling af aminopyrimidinderivater under anvendelse deraf - Google Patents

Mellemprodukter som er anvendelige til syntesen af aminopyrimidinderivater, fremgangsmåde til fremstilling deraf og fremgangsmåde til fremstilling af aminopyrimidinderivater under anvendelse deraf Download PDF

Info

Publication number
DK3658553T3
DK3658553T3 DK18838173.5T DK18838173T DK3658553T3 DK 3658553 T3 DK3658553 T3 DK 3658553T3 DK 18838173 T DK18838173 T DK 18838173T DK 3658553 T3 DK3658553 T3 DK 3658553T3
Authority
DK
Denmark
Prior art keywords
aminopyrimide
derivatives
preparation
synthesis
intermediates useful
Prior art date
Application number
DK18838173.5T
Other languages
English (en)
Inventor
Sang-Ho Oh
Ja-Heouk Khoo
Jong-Chul Lim
Doo-Byung Lee
Jung-Ae Lee
Jun-Sup Lee
Hyun Ju
Woo-Seob Shin
Sang-Seol Jeon
Original Assignee
Yuhan Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuhan Corp filed Critical Yuhan Corp
Application granted granted Critical
Publication of DK3658553T3 publication Critical patent/DK3658553T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/321,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
DK18838173.5T 2017-07-28 2018-07-25 Mellemprodukter som er anvendelige til syntesen af aminopyrimidinderivater, fremgangsmåde til fremstilling deraf og fremgangsmåde til fremstilling af aminopyrimidinderivater under anvendelse deraf DK3658553T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20170096220 2017-07-28
PCT/KR2018/008381 WO2019022486A1 (en) 2017-07-28 2018-07-25 NOVEL INTERMEDIATES USEFUL FOR SYNTHESIZING AMINOPYRIMIDINE DERIVATIVES, PROCESS FOR PREPARING THE SAME, AND PROCESS FOR PREPARING AMINOPYRIMIDINE DERIVATIVES THEREWITH

Publications (1)

Publication Number Publication Date
DK3658553T3 true DK3658553T3 (da) 2022-07-25

Family

ID=65040817

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18838173.5T DK3658553T3 (da) 2017-07-28 2018-07-25 Mellemprodukter som er anvendelige til syntesen af aminopyrimidinderivater, fremgangsmåde til fremstilling deraf og fremgangsmåde til fremstilling af aminopyrimidinderivater under anvendelse deraf

Country Status (26)

Country Link
US (1) US10858353B2 (da)
EP (1) EP3658553B1 (da)
JP (1) JP7216704B2 (da)
KR (1) KR20190013554A (da)
CN (1) CN111032650A (da)
AU (1) AU2018308039B2 (da)
BR (1) BR112020001396A2 (da)
CA (1) CA3069408A1 (da)
CO (1) CO2020000595A2 (da)
DK (1) DK3658553T3 (da)
EA (1) EA038856B1 (da)
ES (1) ES2923278T3 (da)
HR (1) HRP20220848T1 (da)
HU (1) HUE059501T2 (da)
IL (1) IL271974B (da)
LT (1) LT3658553T (da)
MA (1) MA49703A (da)
PH (1) PH12020500070A1 (da)
PL (1) PL3658553T3 (da)
PT (1) PT3658553T (da)
RS (1) RS63497B1 (da)
SA (1) SA520411120B1 (da)
SG (1) SG11201913520YA (da)
SI (1) SI3658553T1 (da)
UA (1) UA125664C2 (da)
WO (1) WO2019022486A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20210304A1 (ar) 2019-05-14 2023-01-30 Janssen Biotech Inc علاجات مركبة باستخدام الأجسام المضادة ثنائية النوعية المضادة لمستقبل عامل نمو البشرة (EGFR)/ مستقبل عامل نمو خلايا الكبد (c-Met) ومثبطات كيناز التيروسين الخاصة بمستقبل عامل نمو البشرة (EGFR) من الجيل الثالث
US11850248B2 (en) 2019-05-14 2023-12-26 Yuhan Corporation Therapies with 3rd generation EGFR tyrosine kinase inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8629132B2 (en) * 2009-11-13 2014-01-14 Genosco Kinase inhibitors
CN105461695B (zh) * 2014-09-29 2018-03-27 齐鲁制药有限公司 嘧啶或三嗪衍生物及其制备方法和用途
MX2017003181A (es) * 2014-10-13 2017-07-20 Yuhan Corp Compuestos y composiciones para modular actividades de quinasa de mutante de receptor del factor de crecimiento epidermico.
CN104788427B (zh) * 2015-02-05 2017-05-31 上海泓博智源医药股份有限公司 3‑(2‑嘧啶氨基)苯基丙烯酰胺类化合物及其应用
EP3312179B1 (en) * 2015-04-29 2019-07-10 Nanjing Sanhome Pharmaceutical Co., Ltd. Fused-ring or tricyclic aryl pyrimidine compound used as kinase inhibitor
US10329257B2 (en) * 2015-08-13 2019-06-25 The Broad Institute, Inc. Compositions and methods for treating tuberculosis
SG11201913556SA (en) 2017-07-28 2020-02-27 Yuhan Corp Intermediates useful for the synthesis of a selective inhibitor against protein kinase and processes for preparing the same

Also Published As

Publication number Publication date
US20200207750A1 (en) 2020-07-02
HUE059501T2 (hu) 2022-11-28
EP3658553A1 (en) 2020-06-03
CA3069408A1 (en) 2019-01-31
RS63497B1 (sr) 2022-09-30
SA520411120B1 (ar) 2022-08-25
EP3658553A4 (en) 2021-04-21
WO2019022486A1 (en) 2019-01-31
UA125664C2 (uk) 2022-05-11
KR20190013554A (ko) 2019-02-11
JP7216704B2 (ja) 2023-02-01
CO2020000595A2 (es) 2020-05-05
IL271974B (en) 2022-08-01
PT3658553T (pt) 2022-09-23
LT3658553T (lt) 2022-09-12
JP2020528437A (ja) 2020-09-24
BR112020001396A2 (pt) 2020-08-11
ES2923278T3 (es) 2022-09-26
PL3658553T3 (pl) 2022-10-10
CN111032650A (zh) 2020-04-17
MA49703A (fr) 2021-04-21
PH12020500070A1 (en) 2020-12-07
SG11201913520YA (en) 2020-02-27
EA038856B1 (ru) 2021-10-28
US10858353B2 (en) 2020-12-08
EA202090385A1 (ru) 2020-09-09
AU2018308039A1 (en) 2020-01-30
AU2018308039B2 (en) 2022-04-14
EP3658553B1 (en) 2022-06-15
SI3658553T1 (sl) 2022-10-28
IL271974A (en) 2020-02-27
HRP20220848T1 (hr) 2022-10-14

Similar Documents

Publication Publication Date Title
DK3524600T3 (da) Fremgangsmåder og mellemprodukter til fremstilling af hidtil ukendte substituerede 6,7-dihydro-5h-benzo[7]annulenforbindelser
DK3312177T3 (da) Tricyklisk derivatforbindelse, fremgangsmåde til at fremstille samme og farmaceutisk sammensætning omfattende samme
DK3728121T3 (da) Lanthaniddoterede, lagdelte dobbelthydroxider og fremgangsmåde til fremstilling af samme
DK3429998T3 (da) Fremgangsmåde til fremstilling af quinolin-2-yl-phenylaminderivater og disses salte
ES2837136R1 (es) Proceso para la preparación de 3alfa-hidroxi-5alfa-pregnan-20-ona (Brexanolona)
DK3390354T3 (da) Fremgangsmåde til tilvejebringelse af carbondioxid til syntese af urea
DK3750893T3 (da) Dioxazolinforbindelse, fremgangsmåde til fremstilling deraf og anvendelser deraf
DK3524609T3 (da) Fremgangsmåde til fremstilling af 3-phenyl-2,3,4,8,9,10-hexahydropyrano[2,3-f]chromenderivater, optiske isomerer deraf og mellemprodukter fra processen
DK3255046T3 (da) Hydroxyethylsulfonat af cyclin-afhængig proteinkinasehæmmer, krystallinsk form deraf og fremgangsmåde til fremstilling deraf
DK3265443T3 (da) Pyrrolidincarboxamidderivater og fremgangsmåde til fremstilling og anvendelse af samme
DK3322776T3 (da) Apparat og fremgangsmåde til fremstilling af syntetisk gas
DK3412673T3 (da) Fremgangsmåde til fremstilling af pyrrolo[3,2-D]pyrimidin-forbindelse og mellemprodukter deraf
DK3390427T3 (da) Fremgangsmåde til fremstilling af degarelix og dets mellemprodukter
DK3480976T3 (da) Tidsjustering til distribueret netværksarkitektur
BR112017019176A2 (pt) processos para a preparação de fluorocetolídeos
DK3442944T3 (da) Fremgangsmåde til fremstillingen af 4-aminoindanderivater og relaterede aminoindanamider
DK3737678T3 (da) Fremgangsmåde til fremstilling af disubstituerede diaryloxybenzoheterodiazolforbindelser
DK3658553T3 (da) Mellemprodukter som er anvendelige til syntesen af aminopyrimidinderivater, fremgangsmåde til fremstilling deraf og fremgangsmåde til fremstilling af aminopyrimidinderivater under anvendelse deraf
DK3459954T3 (da) Ny polymorf af triazolo-pyrazin-derivat og fremgangsmåde til fremstilling af samme
DK3631115T3 (da) Korrugeret konstruktionselement, apparat til fremstilling heraf og fremgangsmåde for fremstilling
DK3475310T3 (da) Umættede derivater af polysaccharider, fremgangsmåder til fremstilling deraf og anvendelse deraf
DK3604303T3 (da) Hidtil ukendt pyrrolopyridinderivat, fremgangsmåde til fremstilling heraf og anvendelse deraf
DK3495339T3 (da) Fremgangsmåde til fremstilling af reaktionsprodukt
DK3207023T3 (da) Fremgangsmåde til fremstilling af 1-(3,5-dichlorphenyl)-2,2,2-trifluorethanon og derivater deraf
DK3439641T3 (da) Sammensætninger, kits og fremgangsmåder til opretholselse af øjenlågshygiejne